Results 81 to 90 of about 456 (124)

Phase 1b safety and pharmacokinetics of intravenous and oral fosmanogepix in patients with acute myeloid leukaemia and neutropenia. [PDF]

open access: yesJ Antimicrob Chemother, 2023
Cornely OA   +8 more
europepmc   +1 more source

Multisystem <i>Lomentospora prolificans</i> progression on fosmanogepix despite <i>in vitro</i> activity: a call for expanding clinical research on novel antifungals. [PDF]

open access: yesASM Case Rep
Cooper RA   +12 more
europepmc   +1 more source

Novel Inositol Acyltransferase (Gwt1) Inhibitor for Fungal Keratitis Treatment: Evaluation of In Vitro and In Vivo Efficacy and Safety. [PDF]

open access: yesInvest Ophthalmol Vis Sci
Gowtham L   +8 more
europepmc   +1 more source

<i>In vitro</i> activity of novel antifungals, natamycin, and terbinafine against <i>Fusarium</i>. [PDF]

open access: yesAntimicrob Agents Chemother
Garbe E   +5 more
europepmc   +1 more source

Emerging antifungal resistance in Candida parapsilosis: the end of the innocence. [PDF]

open access: yesNPJ Antimicrob Resist
Guinea J   +4 more
europepmc   +1 more source

Eumycetoma: pathogenesis, current treatments, and the search for new drugs. [PDF]

open access: yesAppl Microbiol Biotechnol
Yachioui DE   +2 more
europepmc   +1 more source

Studying Candida Biofilms Across Species: Experimental Models, Structural Diversity, and Clinical Implications. [PDF]

open access: yesPharmaceuticals (Basel)
Squitieri D   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy